Related Experiment Video
Updated: Apr 18, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.3K
Abstract:
A new screening platform that uses cells grown from patients' own tumor biopsies may offer a way to rapidly identify drug combinations capable of overcoming resistance to treatment.
Insights
A novel screening platform utilizes patient tumor cells to quickly find effective drug combinations. This approach aims to overcome treatment resistance in cancer therapy.
Area of Science:
- Oncology
- Drug Discovery
- Personalized Medicine
Background:
- Cancer treatment resistance is a significant clinical challenge.
- Current methods for identifying effective drug combinations are often slow and inefficient.
Discussion:
- A new platform uses patient-derived tumor cells for drug screening.
- This method allows for rapid identification of synergistic drug combinations.
- The platform aims to overcome acquired resistance to existing therapies.
Key Insights:
- Patient tumor cells can be cultured to create personalized screening models.
- Rapid screening identifies novel drug combinations to combat treatment resistance.
- This approach holds promise for tailoring cancer treatment strategies.
Outlook:
- Further validation of the platform in diverse cancer types is warranted.
- This technology could accelerate the development of combination therapies.
- Potential for improved patient outcomes through personalized treatment selection.
Related Concept Videos
02:46Genetic Screens
5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K